Gates Foundation – Visterra, Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:September 26, 2023 Post category: Continue ReadingGates Foundation – Visterra, Strategic Relationship Letter Agreement
University of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement Post author:GHIAA Admin Post published:September 26, 2023 Post category: Continue ReadingUniversity of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement
CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement Post author:GHIAA Admin Post published:September 18, 2023 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement
U.S. Department of Defense – Inovio, COVID-19 Vaccine Delivery Device, Other Transaction Prototype Agreement Post author:GHIAA Admin Post published:September 4, 2023 Post category: Continue ReadingU.S. Department of Defense – Inovio, COVID-19 Vaccine Delivery Device, Other Transaction Prototype Agreement
NIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement Post author:GHIAA Admin Post published:September 4, 2023 Post category: Continue ReadingNIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement
PHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement Post author:GHIAA Admin Post published:September 4, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement
PHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement Post author:GHIAA Admin Post published:August 30, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement
PHS – Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement Post author:GHIAA Admin Post published:August 29, 2023 Post category: Continue ReadingPHS – Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement
PHS – Biosyn, HIV Prophylactic Exclusive License Agreement Post author:GHIAA Admin Post published:August 25, 2023 Post category: Continue ReadingPHS – Biosyn, HIV Prophylactic Exclusive License Agreement